R&D

21세기를 주도하는 바이오 업계의 선두주자가 되기 위해 항상 최선을 다하는 기업

  • 논문

    국가과제

    특허출원

    • 번호
    • 구분
    • 논문명
    • 년도

    No.58

    Circulating RNA Profiling in Postreperfusion Plasma From Kidney Transplant Recipients

    Kidney Transplant

    Circulating RNA Profiling in Postreperfusion Plasma From Kidney Transplant Recipients

    2021

    No.57

    Human delta like 1-expressing human mesenchymal stromal cells promote human T cell development and antigen-specific response in humanized NOD/SCID/IL-2R[Formula: see text] null (NSG) mice

    Hu-mouse

    Human delta like 1-expressing human mesenchymal stromal cells promote human T cell development and antigen-specific response in humanized NOD/SCID/IL-2R[Formula: see text] null (NSG) mice

    2021

    No.56

    Optimal allogeneic islet dose for transplantation in insulin-dependent diabetic Macaca fascicularis monkeys

    Islet

    Optimal allogeneic islet dose for transplantation in insulin-dependent diabetic Macaca fascicularis monkeys

    2021

    No.55

    Anti-tumor Effects of anti-PD-1 Antibody, Pembrolizumab, in Humanized NSG PDX Mice Xenografted With Dedifferentiated Liposarcoma

    Sarcoma

    Anti-tumor Effects of anti-PD-1 Antibody, Pembrolizumab, in Humanized NSG PDX Mice Xenografted With Dedifferentiated Liposarcoma

    2020

    No.54

    Integrated whole liver histologic analysis of the allogeneic islet distribution and characteristics in a nonhuman primate model

    Islet

    Integrated whole liver histologic analysis of the allogeneic islet distribution and characteristics in a nonhuman primate model

    2020

    No.53

    Comparative study of human and cynomolgus T-cell depletion with rabbit anti-thymocyte globulin (rATG) treatment-for dose adjustment in a non-human primate kidney transplantation model

    Kidney Transplant

    Comparative study of human and cynomolgus T-cell depletion with rabbit anti-thymocyte globulin (rATG) treatment-for dose adjustment in a non-human primate kidney transplantation model

    2019

    No.52

    Multi-layer surface modification of pancreatic islets for magnetic resonance imaging using ferumoxytol.

    Islet

    Multi-layer surface modification of pancreatic islets for magnetic resonance imaging using ferumoxytol.

    2019

    No.51

    Relationships between Cytokine Levels and Disease Parameters during the Development of a Collagen-induced Arthritis Model in Cynomolgus Macaques (Macaca fascicularis).

    autoimmune disease

    Relationships between Cytokine Levels and Disease Parameters during the Development of a Collagen-induced Arthritis Model in Cynomolgus Macaques (Macaca fascicularis).

    2019

    No.50

    Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells

    Sarcoma

    Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells

    2019

    No.49

    Reconstituting human cutaneous regeneration in humanized mice under endothelial cell therapy

    Hu-mouse

    Reconstituting human cutaneous regeneration in humanized mice under endothelial cell therapy

    2019

    No.48

    Reduced variability in pharmacokinetics of tacrolimus following intramuscular injection compared to oral administration in Cynomolgus monkeys: investigating optimal dosing regimens

    Non-Human Primates

    Reduced variability in pharmacokinetics of tacrolimus following intramuscular injection compared to oral administration in Cynomolgus monkeys: investigating optimal dosing regimens

    2019

    No.47

    Establishment of a novel PDX mouse model and evaluation of the tumor suppression efficacy of bortezomib against liposarcoma

    Sarcoma

    Establishment of a novel PDX mouse model and evaluation of the tumor suppression efficacy of bortezomib against liposarcoma

    2019

    No.46

    Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells

    Hepatocyte

    Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells

    2019

    No.45

    CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus.

    autoimmune disease

    CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus.

    2018

    No.44

    Ectopic vascularized bone formation by human umbilical cord-derived mesenchymal stromal cells expressing bone morphogenetic factor-2 and endothelial cells

    MSC

    Ectopic vascularized bone formation by human umbilical cord-derived mesenchymal stromal cells expressing bone morphogenetic factor-2 and endothelial cells

    2018

    • 번호
    • 사업명
    • 연구과제명
    • 관리기관
    • 연구기간

    No. 1

    이종이식제제 관리기준 마련 - 원료동물의 관리 및 이종이식제제 품질평가법 개발 연구

    2022년 1차 용역연구개발과제

    이종이식제제 관리기준 마련 - 원료동물의 관리 및 이종이식제제 품질평가법 개발 연구

    식품의약품안전처

    2022-02-01~2023-11-30

    No. 2

    코로나19 DNA 백신 GX-19N의 임상1/2a상 개발 및 임상 2b/3상 승인

    코로나19 백신 임상지원

    코로나19 DNA 백신 GX-19N의 임상1/2a상 개발 및 임상 2b/3상 승인

    범부처신약개발사업단

    2020-09-15~2021-09-14

    No. 3

    메타 소프트오간모듈 제작 기술 및 모듈 어셈블리 로봇 시스템 개발

    2020년도 산업기술 알키미스트 프로젝트

    메타 소프트오간모듈 제작 기술 및 모듈 어셈블리 로봇 시스템 개발

    산업통상자원부

    2020-09-01~2022-02-28

    No. 4

    비감염성질환 예방과 치료를 위한 myostatin 형질전환 소 개발

    기본연구개발사업

    비감염성질환 예방과 치료를 위한 myostatin 형질전환 소 개발

    한국연구재단

    2020-06-01~2023-02-28

    No. 5

    무균/형질전환 돼지의 영장류 이종장기 이식을 통한 이종 장기 임상 적용 가능성 검증

    첨단의료기술개발사업

    무균/형질전환 돼지의 영장류 이종장기 이식을 통한 이종 장기 임상 적용 가능성 검증

    보건복지부

    2020-04-23~2022-12-31

    No. 6

    PD-L1에 hyFc 영역을 포함하는 신규 면역억제제 개발 및 사업화

    2020상반기 IP-R&D 전략사업

    PD-L1에 hyFc 영역을 포함하는 신규 면역억제제 개발 및 사업화

    한국특허전략개발원

    2020-04-13~2020-09-28

    • 번호
    • 년도
    • 특허명